Skip to content
DataLookout
Menu

NCT05571618

The Rechallenge of ADCs in MBC Patients

StatusUnknown
PhaseNot specified
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 3 versions: 2 with changes below, 1 re-verified with no change.

  1. Minor Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Active, Not Recruiting
  2. Minor Primary completion date: Sep 1, 2024 to Jan 1, 2025
    • Study completion date: Sep 1, 2024 to Mar 1, 2025
    v3
  3. Study First Submitted
  • Minor: routine updates

Endpoints

Primary

PFS
Timeframe: 6 weeks

Secondary (5)

ORR
CBR
DoR
Adverse events
OS

Arms and interventions

Group1

Drugs: ADC

Sites

1 site in 1 country

  • Fudan University Shanghai Cancer CenterShanghai, Shanghai Municipality, China